Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

KovsieFit caters for all
2016-05-30


KovsieFit offers a new service to students and staff for keeping fit. Photo: Charl Devenish

Students on the Bloemfontein Campus of the University of the Free State (UFS) can now work in a gym session between classes, and staff can do the same before or after work.

This is due to KovsieFit, a commercial gymnasium, which will be taking in its first members on 30 May 2016. The gym is located in the Callie Human Centre and is a project which has been a long-time dream for the UFS.

UFS boasts three gymnasiums

For the last couple of months, a lot of hard work went on behind the scenes. Kobus Calldo, conditioning coach at KovsieSport, says everybody involved with the process is happy that KovsieFit is a reality. According to him KovsieFit “is looking good and everybody involved is very satisfied” with the final product.

KovsieFit will be open Mondays to Fridays from 05:30 to 19:30, and on Saturdays from 07:00 to 11:00. Prospective members will have to undergo health screenings before they may join. KovsieFit also has lockers available. The gym will be managed by a committee.

The High Performance Centre of the UFS, where athletes and sports teams are training, is located next to KovsieFit. At the beginning of the year, KovsieSport’s offices also moved to the Callie Human Centre. A third gymnasium, the Sports Science Centre – the former Biokinetics gymnasium – is located next to the Mabaleng Building. This will mainly be used as a rehabilitation centre.

Service to university community

According to Calldo KovsieFit caters for all and offers the same service to its members as any other commercial gymnasium. The target mark is primarily students and staff, and then the rest of the city.

“It is cheaper and conveniently close to the residences for students on campus. Staff members can have a gym session during lunch or before or after work.”

Wide variety of exercises

“We offer spinning, pilates, aerobic, zumba, and all those type of classes too. We will start with four classes a day until business picks up,” Calldo says.

KovsieFit also offers aerobic apparatus such as treadmills, rowers, and electric bicycles. A gymnasium circuit, two Olympic platforms, and different types of weights and machines are also available.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept